Clinical Trials
4
Active:3
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
Phase 3
Terminated
- Conditions
- Allogeneic Stem Cell Transplantation
- Interventions
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2012-12-10
- Lead Sponsor
- Pierrel Research Europe GmbH
- Target Recruit Count
- 212
- Registration Number
- NCT01185223
- Locations
- 🇦🇹
Pierrel Site 50, Vienna, Austria
🇩🇪Pierrel Site 12, Berlin, Germany
🇩🇪Pierrel Site 13, Berlin, Germany
News
No news found